Table 2.
Baseline demographic, clinical, and psychological characteristics stratified by group.
| Characteristic | Completers, n=34 | Treatment dropout, n=88 | Dropout, n=24 | P | |
| mean (SD) or n (%) | |||||
| Demographic | |||||
|
|
Age, mean (SD) | 57.91 (9.82) | 58.84 (9.84) | 56.42 (10.20) | .56 |
|
|
Gender (male) | 28 (82.4%) | 74 (84.1%) | 18 (75.0%) | .59 |
|
|
Employed | 15 (44.1%) | 38 (43.2%) | 15 (62.5%) | .23 |
|
|
Has partner | 30 (88.2%) | 73 (83.0%) | 21 (87.5%) | .71 |
|
|
High education | 26 (76.5%) | 65 (74.7%) | 15 (62.5%) | .43 |
| Clinical | |||||
|
|
LVEF≤35a | 21 (61.8%) | 52 (59.1%) | 14 (58.3%) | .96 |
|
|
QRS≥120b | 12 (36.4%) | 37 (42.5%) | 10 (41.7%) | .83 |
|
|
NYHA III/IVc | 4 (13.3%) | 13 (20.0%) | 3 (15.0%) | .69 |
|
|
Heart failure | 18 (52.9%) | 46 (52.3%) | 14 (58.3%) | .87 |
|
|
CCId, mean (SD) | 1.88 (1.15) | 1.56 (1.10) | 1.38 (0.65) | .16 |
|
|
Beta-blockers | 28 (82.4%) | 69 (78.4%) | 20 (83.3%) | .81 |
|
|
ACE-inhibitors | 18 (52.9%) | 52 (59.1%) | 12 (50.0%) | .66 |
|
|
Diuretics | 16 (47.1%) | 43 (48.9%) | 13 (54.2%) | .86 |
|
|
Psychotropics | 1 (2.9%) | 9 (10.2%) | 3 (12.5%) | .36 |
| Psychological | |||||
|
|
Anxiety, mean (SD) | 5.46 (5.18) | 4.21 (5.08) | 4.63 (4.62) | .47 |
|
|
Depression, mean (SD) | 6.53 (4.40) | 5.79 (5.38) | 5.58 (5.17) | .73 |
|
|
Type D | 7 (20.6%) | 14 (15.9%) | 3 (12.5%) | .70 |
|
|
Optimism, mean (SD) | 11.12 (2.71) | 11.41 (2.74) | 10.75 (2.44) | .55 |
|
|
Pessimism, mean (SD) | 6.15 (4.16) | 5.56 (3.40) | 5.79 (2.99) | .71 |
aLVEF: left ventricular ejection fraction
bQRS-width: electrocardiogram Q,R, and S waves
cNYHA: New York Heart Association functional class
dCCI: Charlson Comorbidity Index